-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Tipiracil Hydrochloride + Trifluridine) in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Tipiracil Hydrochloride + Trifluridine) in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Tipiracil Hydrochloride + Trifluridine) in Esophageal Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Censavudine in Progressive Supranuclear Palsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Censavudine in Progressive Supranuclear Palsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Censavudine in Progressive Supranuclear Palsy Drug Details: Censavudine (Festinavir, BMS-986001,OBP-601)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UPB-101 in Asthma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. UPB-101 in Asthma Drug Details: UPB-101 is under development for the treatment of severe asthma, chronic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rhenium (186Re) Obisbemeda in Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rhenium (186Re) Obisbemeda in Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rhenium (186Re) Obisbemeda in Leptomeningeal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Lewy Body Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Lewy Body Dementia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buntanetap Tartrate in Lewy Body Dementia Drug Details: Buntanetap (ANVS-401...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rotigotine ER in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rotigotine ER in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rotigotine ER in Frontotemporal Dementia (FTD) Drug Details: Rotigotine (Neupro,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buntanetap Tartrate in Parkinson's Disease Drug Details: Buntanetap (ANVS-401 (Posiphen)) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buntanetap Tartrate in Alzheimer's Disease Drug Details: Buntanetap (ANVS-401 (Posiphen)) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VES-001 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VES-001 in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VES-001 in Frontotemporal Dementia (FTD) Drug Details: VES-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamitresgene Autoleucel in Bladder Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Afamitresgene Autoleucel in Bladder Cancer Drug Details: ADPA-2M4 is under development for the treatment of...